Rx Processing Corp. Chairman Peter Fiorillo Continues Mission for Uninsured


TAMPA, Fla., Aug. 10, 2007 (PRIME NEWSWIRE) -- Rx Processing Corporation (Pink Sheets:RXPC) announces today after careful consideration the Chairman / CEO will continue mission for the under and uninsured and all mankind.

Rx Processing Corp., CEO will continue to protect the mission and potentially increase shareholder value in the near future as he expands our company through a merger, asset purchase, buyout, or any corporate measure to secure long-term business interests.

Chairman Peter Fiorillo stated, "The years at the helm of Rx Processing Corp. have taught me affordable Health care is a universal concern. I will set the example today and in the future by embodying and instilling a staple focus of our corporate philosophy learned from my mentor and friend Tim Gillesse; it states 'Persevere ye perfect man, forever hold these precepts Ten.'"

Rx Processing Corp., an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed through storefront locations, is deploying a direct to consumer delivery business model that fulfills the needs of under and uninsured clients' health care needs. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.

Safe Harbor Statement:

All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.


            

Contact Data